[ABEO] Abeona Therapeutics Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 4.8 Change: 0.15 (3.23%)
Ext. hours: Change: 0 (0%)

chart ABEO

Refresh chart

Strongest Trends Summary For ABEO

ABEO is in the medium-term down -18% below S&P in 6 months and down -72% below S&P in 1 year. In the long-term down -88% below S&P in 3 years and down -100% below S&P in 29 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-400 K Cash From Investing Activities-10 K Cash From Operating Activities-3.16 M Gross Profit
Net Profit-2 M Operating Profit-2 M Total Assets13.12 M Total Current Assets8.19 M
Total Current Liabilities1.24 M Total Debt Total Liabilities9.96 M Total Revenue260 K
Technical Data
High 52 week11.9 Low 52 week1.54 Last close2.71 Last change24.88%
RSI53.61 Average true range0.23 Beta0.56 Volume171.07 K
Simple moving average 20 days7.99% Simple moving average 50 days9.65% Simple moving average 200 days-49.94%
Performance Data
Performance Week18.34% Performance Month-9.36% Performance Quart-30.87% Performance Half-66.63%
Performance Year-73.94% Performance Year-to-date-62.04% Volatility daily7.18% Volatility weekly16.05%
Volatility monthly32.9% Volatility yearly113.97% Relative Volume134.28% Average Volume1.12 M
New High New Low

News

2020-05-28 11:30:03 | Is Abeona Therapeutics ABEO Outperforming Other Medical Stocks This Year?

2020-05-28 08:30:10 | Abeona Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference

2020-05-08 16:27:32 | Edited Transcript of ABEO earnings conference call or presentation 7-May-20 12:30pm GMT

2020-05-08 12:58:04 | Pacira's PCRX Q1 Earnings Top Estimates, Revenues Rise Y/Y

2020-05-07 13:59:05 | Horizon Therapeutics' HZNP Q1 Earnings Beat Estimates

2020-05-06 16:14:40 | Abeona Therapeutics Reports First Quarter Financial Results and Business Updates

2020-04-29 11:08:03 | Moving Average Crossover Alert: Abeona Therapeutics

2020-04-21 16:04:10 | Abeona Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635c4

2020-04-21 08:00:10 | Abeona Therapeutics Appoints Brian Pereira and Shawn Tomasello to the Board of Directors

2020-04-20 08:43:12 | Implied Volatility Surging for Abeona Therapeutics ABEO Stock Options

2020-04-20 06:06:29 | Investors Who Bought Abeona Therapeutics NASDAQ:ABEO Shares A Year Ago Are Now Down 71%

2020-04-17 07:00:10 | INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Abeona Therapeutics Inc. for Potential Breach of Fiduciary Duty Claims

2020-04-06 09:16:01 | Is Abeona Therapeutics ABEO Stock a Solid Choice Right Now?

2020-03-27 18:19:14 | Abeona Therapeutics Stakeholder Letter in Response to the COVID-19 Pandemic

2020-03-23 12:00:04 | Abeona Therapeutics ABEO Moves to Buy: Rationale Behind the Upgrade

2020-03-17 22:10:21 | Edited Transcript of ABEO earnings conference call or presentation 17-Mar-20 2:00pm GMT

2020-03-17 07:30:10 | Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

2020-03-16 16:20:15 | Abeona Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Business Updates

2020-02-26 08:00:10 | Abeona Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference

2020-02-21 08:45:01 | Is the Options Market Predicting a Spike in Abeona ABEO Stock?

2020-02-12 14:15:10 | Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™

2020-01-21 08:00:10 | Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa

2020-01-15 09:33:08 | Abeona Therapeutics Announces Issuance of U.S. Patent for AIM™ Capsids

2020-01-13 09:00:10 | Abeona Therapeutics Initiates Pivotal Phase 3 Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

2020-01-02 12:12:00 | THURSDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abeona Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm

2020-01-02 10:28:00 | DEADLINE ALERT - Abeona Therapeutics Inc. ABEO - Bronstein, Gewirtz & Grossman, LLC Reminds Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: January 2, 2019

2020-01-02 04:52:07 | Insider Buying: The Abeona Therapeutics Inc. NASDAQ:ABEO Just Bought US$500k Worth Of Shares

2019-12-31 12:30:00 | THURSDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm

2019-12-31 12:00:10 | ABEONA EQUITY LOSS ALERT: ROSEN, A LEADING LAW FIRM, Reminds Abeona Therapeutics Inc. Investors of Important Thursday Deadline in Securities Class Action - ABEO

2019-12-27 20:30:00 | 6-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm

2019-12-27 18:00:00 | DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Abeona Therapeutics, Inc. and Encourages Investors to Contact the Firm

2019-12-24 14:20:00 | SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm

2019-12-24 13:30:10 | ROSEN, A TOP RANKED LAW FIRM, Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEO

2019-12-24 13:01:10 | Abeona Announces Closing of $103.5 Million Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

2019-12-20 18:20:00 | FINAL DEADLINE APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm

2019-12-20 10:44:27 | Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA

2019-12-20 10:22:03 | Are Options Traders Betting On A Big Move In Abeona Therapeutics ABEO Stock?

2019-12-20 10:00:10 | Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. ABEO, AZZ, Inc. AZZ & Twitter, Inc. TWTR 

2019-12-20 09:24:07 | Abeona Announces Pricing of Public Offering of Common Stock and Pre?Funded Warrants

2019-12-19 17:20:54 | Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants

2019-12-19 17:00:00 | IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm

2019-12-19 13:03:00 | Abeona Deadline Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm

2019-12-18 15:59:37 | ABEO NOTICE: Pawar Law Group Reminds Investors of JANUARY 2 Deadline in Securities Class Action Lawsuit Against Abeona Therapeutics Inc.– ABEO

2019-12-17 14:25:27 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline – ABEO

2019-12-16 19:10:00 | SHAREHOLDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm

2019-12-16 10:51:00 | Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Abeona Therapeutics Inc. ABEO, AZZ, Inc. AZZ & Twitter, Inc. TWTR

2019-12-16 10:22:00 | Abeona Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Abeona Therapeutics Inc. To Contact The Firm

2019-12-15 10:00:10 | ABEO LOSS ALERT: TOP RANKED ROSEN LAW FIRM Reminds Abeona Therapeutics Inc. Investors of Important Deadline in Securities Class Action – ABEO

2019-12-14 09:36:00 | SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Abeona Therapeutics Inc. of Class Action Lawsuit and Upcoming Deadline - ABEO

2019-12-13 16:30:00 | INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abeona Therapeutics Inc. and Encourages Investors with Losses in Excess of $200,000 to Contact the Firm